@Ghoshomyi
iAccount based inUnited States
About this account
- Account based in
- United States
- Connected via
- United States App Store
Account-level information from X, not a live location or the device used for a specific post.
Physician Scientist in drug development | Alum of Adult BMT/ Cell Therapy/ Med Oncology Fellowship Memorial Sloan Kettering Cancer Center | IM Residency MSSM
New York, USA
Joined February 2016
- Tweets1.5K
- Following371
- Followers968
- Likes3.6K
Pinned Tweet
Gabe(3rd grade): But I can tell you, if you get brain cancer, try not to worry! Fight #PedsCancer @sloan_kettering nitter.cf/sloan_kettering/status…
Check it out! Our Department of Pediatrics is currently being featured by @humansofny: facebook.com/humansofnewyork…
Arnab Ghosh retweeted
I’m honored to be selected for the 2026 @SimonsFdn Fellows-to-Faculty Award to support my research on #RNA regulation in the #Aging brain @RockefellerUniv and beyond. I’m excited to join the Simons Foundation community!
We're pleased to announce the 2026 class of our Fellows-to-Faculty program!
This fellowship supports talented early-career scientists as they transition into tenure-track faculty positions in autism and #neuroscience research.
See the new class: bit.ly/4yXUjrd
#science #autismresearch
Arnab Ghosh retweeted
🚨 “I could never have become CEO in India. America's meritocratic system rewards talent, regardless of gender or ethnicity. They just want the best brains to rise to the top.”
— Indra Nooyi, former Chairperson and CEO of PepsiCo.
Arnab Ghosh retweeted
Spotted at #ASCO26: MSK’s Dr. @AlanHoMDPhD and @AliSchram featured as @ConquerCancerFd grant recipients 👏 – at Chicago, IL
Anyone who has lost a friend or family member to pancreatic cancer knows that it has dismal outcomes. This progress is incredible.
It represents the best of America. Sloan Kettering is a world renowned research institution. And Dr. Balachandran is the son of Indian immigrants.
Pancreatic cancer mRNA vaccine shows lasting results in an early trial. Scientists caution that more research is needed, but nearly all of the patients who responded to the personalized vaccine are still alive six years later.
nbcnews.com/health/cancer/pa…
Arnab Ghosh retweeted
🚨 An experimental, personalized vaccine using #mRNA to prevent #pancreaticcancer from returning after surgery continues to show promise in a small, 16-person patient group.
New results from a phase 1 clinical trial, being presented at #AACR26, show that nearly 90% of people whose immune systems responded to the vaccine were still alive six years later.
“These early results show this new immunotherapy approach has the potential to be groundbreaking for one of the deadliest cancers,” says MSK physician-scientist Dr. Vinod Balachandran (@TheVinodLab), the trial’s principal investigator and Director of The Olayan Center for Cancer Vaccines.
Learn more about these findings: bit.ly/3QuIiaL @AACR
Arnab Ghosh retweeted
Located in the Canadian High Arctic, Baffin Island is the fifth largest island in the world. In this land of the midnight sun and polar nights, where a handful of Inuit communities endure, you would find a hill named after a Bengali Major. Thread.
1/19
Yoo-hoo @CentralParkWMD
A new drug is showing promise in lung and pancreatic cancers (two of the most aggressive forms of cancer) by targeting one of the most common cancer-driving mutations.
Researchers at Memorial Sloan Kettering Cancer Center (MSK), including gastrointestinal medical oncologist @CentralParkWMD who led the global phase 1 clinical trial, shared results published in the @NEJM.
The trial tested setidegrasib, a drug that tags and destroys the cancer-causing protein produced by the KRAS G12D mutation. This new method for targeting a long-known mutation is called a KRAS degrader.
KRAS mutations are present in about 1 in 5 cancers. The G12D subtype drives about 40% of pancreatic cancers and 5% of non-small cell lung cancers.
“This drug’s potential is exciting,” says Dr. Park, “because the trial results suggest that setidegrasib can not only extend life for some patients with these aggressive cancers, it also has a very good safety profile, meaning the drug was well-tolerated with side effects that can be managed quite easily."
Learn more about this research: bit.ly/4lSeoJa
Arnab Ghosh retweeted
Just in: Good news for the myeloma field.
FDA approves teclistamab plus daratumumab (Tec-Dara) combination for myeloma for patients who have had at least one prior line of therapy.
Note: Always use Tec-Dara with monthly IVIG. It’s not optional.
That was fast! And this is unprecedented curve is why.
Arnab Ghosh retweeted
Academic Oncology at a Crossroads: Rebuilding a Sustainable Career Path
@JNCCN #MedTwitter #academia
“Academic oncology faces a quiet crisis that is becoming very loud. After a decade of training beyond medical school, our brightest oncologists are walking away from academia—not from lack of passion, but because the academic system has become fundamentally broken.”
➡️ jnccn.org/view/journals/jncc…
Arnab Ghosh retweeted
Enjoyed being featured in the Lancet Neurology Lifeline series. Thank you @TheLancetNeuro for the invitation! Krithi Irmady - The Lancet Neurology thelancet.com/journals/laneu…
Arnab Ghosh retweeted
Photo of the year for myeloma:
Cilta-cel in multi-drug refractory disease
From Jagannath, @PlasmaCellPete et al @JCO_ASCO #ASCO25
Arnab Ghosh retweeted
“The most effective way to prevent the spread of measles is the MMR vaccine.”
Important message from @SecKennedy. Completely agree and encourage all parents to make sure their children are vaccinated against measles.
I came to Gaines County, Texas, today to comfort the Hildebrand family after the loss of their 8-year-old daughter Daisy. I got to know the family of 6-year-old Kayley Fehr after she passed away in February. I also developed bonds with and deep affection for other members of this community during that difficult time. My intention was to come down here quietly to console the families and to be with the community in their moment of grief.
I am also here to support Texas health officials and to learn how our HHS agencies can better partner with them to control the measles outbreak, which as of today, there are 642 confirmed cases of measles across 22 states, 499 of those in Texas.
In early March, I deployed a CDC team to bolster local and state capacity for response across multiple Texas regions, supply pharmacies and Texas run clinics with needed MMR vaccines and other medicines and medical supplies, work with local schools and healthcare facilities to support contact investigations, and to reach out to communities, including faith leaders, to answer any questions or respond to locations seeking healthcare. Since that time, the growth rates for new cases and hospitalizations have flattened. The most effective way to prevent the spread of measles is the MMR vaccine. I’ve spoken to Governor Abbott, and I’ve offered HHS’ continued support. At his request, we have redeployed CDC teams to Texas. We will continue to follow Texas’ lead and to offer similar resources to other affected jurisdictions.
Arnab Ghosh retweeted
What happens when a cancer researcher becomes a patient herself—and then sets out to change the future of myeloma care? 👩🔬
Our Chief Medical Officer @DrGwenNichols sat down with @UrviShahMD for a conversation you don’t want to miss 👉 bit.ly/4c5Zx90
Arnab Ghosh retweeted
Today's cover: MTA greenlights $250M for consultants to expand Second Avenue subway — at expected cost of $4.3B per mile to build trib.al/UFOY4Nq
Pretty neat @AshTewariMD
Met Mr. @VivekGRamaswamy and his father-in-law in Washington DC. We talked about diverse issues including innovation, culture and more.